Gene · 3535
Papers1,872
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,872
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Molecular Landscape of Primary CNS Lymphomas (PCNSLs) in Children and Young Adults. | Cancers (Basel) | 2024 | 38730692 | PubTator, text mining | PubMed |
| Clonotypic VDJ Rearrangements in Mixed Phenotype Acute Leukemia can be Successfully Utilized to Track Minimal Residual Disease. | Appl Immunohistochem Mol Morphol | 2024 | 38695552 | PubTator, text mining | PubMed |
| Immunogenetics in hematopathology and hematology: why a common language is important. | Leukemia | 2024 | 38664547 | PubTator, text mining | PubMed |
| Functional genomics identifies N-acetyllactosamine extension of complex N-glycans as a mechanism to evade lysis by natural killer cells. | Cell Rep | 2024 | 38619967 | PubTator, text mining | PubMed |
| Primary anaplastic lymphoma kinase-positive large B-cell lymphoma of the left bulbar conjunctiva: A case report. | World J Clin Cases | 2024 | 38322452 | PubTator, text mining | PubMed |
| Mutation-specific CAR T cells as precision therapy for IGLV3-21R110 expressing high-risk chronic lymphocytic leukemia. | Nat Commun | 2024 | 38307904 | PubTator, text mining | PubMed |
| Molecular pathology assists the diagnosis of lymphoepithelial sialadenitis, Sjögren's syndrome and extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue. | J Dent Sci | 2024 | 38303804 | PubTator, text mining | PubMed |
| From MASH to HCC: the role of Gas6/TAM receptors. | Front Immunol | 2024 | 38298195 | PubTator, text mining | PubMed |
| Breaking paradigms: Long non-coding RNAs forming gene fusions with potential implications in cancer. | Genes Dis | 2024 | 38292185 | PubTator, text mining | PubMed |
| RNA processing mechanisms contribute to genome organization and stability in B cells. | Oncogene | 2024 | 38287115 | PubTator, text mining | PubMed |
| An overview of multiple myeloma: A monoclonal plasma cell malignancy's diagnosis, management, and treatment modalities. | Saudi J Biol Sci | 2024 | 38283805 | PubTator, text mining | PubMed |
| Kidins220 regulates the development of B cells bearing the λ light chain. | Elife | 2024 | 38271217 | PubTator, text mining | PubMed |
| The multilevel extensive diversity across the cynomolgus macaque captured by ultra-deep adaptive immune receptor repertoire sequencing. | Sci Adv | 2024 | 38266093 | PubTator, text mining | PubMed |
| Comprehensive characterization and database construction of immune repertoire in the largest Chinese glioma cohort. | iScience | 2024 | 38205245 | PubTator, text mining | PubMed |
Cabozantinib plus atezolizumab in previously untreated advanced hepatocellular carcinoma and previously treated gastric cancer and gastroesophageal junction adenocarcinoma: results from two expansion cohorts of a multicentre, open-label, phase 1b trial (COSMIC-021). | EClinicalMedicine | 2024 | 38204489 | PubTator, text mining | PubMed |
| A comprehensive proteomic profiling of urinary exosomes and the identification of early non-invasive biomarker in patients with coronary artery disease. | J Proteomics | 2024 | 38151158 | PubTator, text mining | PubMed |
| Language model-based B cell receptor sequence embeddings can effectively encode receptor specificity. | Nucleic Acids Res | 2024 | 38109302 | PubTator, text mining | PubMed |
| ETV4-Dependent Transcriptional Plasticity Maintains MYC Expression and Results in IMiD Resistance in Multiple Myeloma. | Blood Cancer Discov | 2024 | 37934799 | PubTator, text mining | PubMed |
| Transcriptional Heterogeneity Overcomes Super-Enhancer Disrupting Drug Combinations in Multiple Myeloma. | Blood Cancer Discov | 2024 | 37767768 | PubTator, text mining | PubMed |
| Metastatic site patterns by intrinsic subtype and HER2DX in early HER2-positive breast cancer. | J Natl Cancer Inst | 2024 | 37676829 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3535/papers?page=4